Inspire Medical Systems, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-13
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $196.92, a 24.52% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $260.89, a 14.23% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $228.40, a 10.26% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $177.99, a 30.80% decline from fiscal 2023.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $257.22, a 18.07% increase from fiscal 2022.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $217.85, a 1.17% increase from fiscal 2021.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $215.34, a 34.87% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-04 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-05 | |||
| 2024-12-31 | $177.99 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $177.99 10-Q · filed 2024-11-04 | |||
| 2024-06-30 | $195.77 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | $196.92 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $257.22 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $264.13 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $265.06 10-Q · filed 2023-08-01 | |||
| 2023-03-31 | $260.89 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $217.85 10-K · filed 2025-02-10 | |||
| 2022-09-30 | $215.17 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | $220.52 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | $228.40 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | $215.34 10-K · filed 2024-02-09 | |||
| 2021-09-30 | $208.12 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $205.65 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $207.15 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | $159.67 10-K · filed 2023-02-10 | |||
| 2020-09-30 | $85.03 10-Q · filed 2020-11-02 | |||
| 2020-06-30 | $77.12 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $71.13 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | $67.43 10-K · filed 2022-02-15 | |||
| 2019-09-30 | $60.37 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | $53.44 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $53.69 10-Q · filed 2019-05-07 | |||
| 2018-12-31 | $31.91 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $15.04 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $12.40 10-Q · filed 2018-08-07 | |||
| 2017-12-31 | $0.94 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $1.65 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |